• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症相关血栓形成:超越临床实践指南——多学科(SEMI-SEOM-SETH)专家共识

Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus.

作者信息

Pachón Vanessa, Trujillo-Santos Javier, Domènech Pere, Gallardo Enrique, Font Carmen, González-Porras José Ramón, Pérez-Segura Pedro, Maestre Ana, Mateo José, Muñoz Andrés, Peris María Luisa, Lecumberri Ramón

机构信息

Department of Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Department of Internal Medicine, Hospital Universitario Santa Lucía, Cartagena, Spain.

出版信息

TH Open. 2018 Nov 5;2(4):e373-e386. doi: 10.1055/s-0038-1675577. eCollection 2018 Oct.

DOI:10.1055/s-0038-1675577
PMID:31249964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6524906/
Abstract

Despite the growing interest and improved knowledge about venous thromboembolism in cancer patients in the last years, there are still many unsolved issues. Due to the limitations of the available literature, evidence-based clinical practice guidelines are not able to give solid recommendations for challenging scenarios often present in the setting of cancer-associated thrombosis (CAT). A multidisciplinary expert panel from three scientific societies-Spanish Society of Internal Medicine (SEMI), Spanish Society of Medical Oncology (SEOM), and Spanish Society Thrombosis and Haemostasis (SETH)-agreed on 12 controversial questions regarding prevention and management of CAT, which were thoroughly reviewed to provide further guidance. The suggestions presented herein may facilitate clinical decisions in specific complex circumstances, until these can be made leaning on reliable scientific evidence.

摘要

尽管在过去几年中,人们对癌症患者静脉血栓栓塞的兴趣日益浓厚,相关知识也有所增加,但仍有许多未解决的问题。由于现有文献的局限性,基于证据的临床实践指南无法针对癌症相关血栓形成(CAT)中常见的具有挑战性的情况给出可靠的建议。来自三个科学协会——西班牙内科协会(SEMI)、西班牙医学肿瘤学协会(SEOM)和西班牙血栓与止血协会(SETH)——的多学科专家小组就12个关于CAT预防和管理的争议性问题达成了一致意见,并对这些问题进行了全面审查以提供进一步指导。本文提出的建议可能会在特定复杂情况下促进临床决策,直到能够依据可靠的科学证据做出决策。

相似文献

1
Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines-A Multidisciplinary (SEMI-SEOM-SETH) Expert Consensus.癌症相关血栓形成:超越临床实践指南——多学科(SEMI-SEOM-SETH)专家共识
TH Open. 2018 Nov 5;2(4):e373-e386. doi: 10.1055/s-0038-1675577. eCollection 2018 Oct.
2
[Polish guidelines for the prevention and treatment of venous thromboembolism. 2012 update].[波兰静脉血栓栓塞症防治指南。2012年更新版]
Pol Arch Med Wewn. 2012;122 Suppl 2:3-74.
3
Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH.肝细胞癌的诊断与治疗。AEEH、AEC、SEOM、SERAM、SERVEI及SETH共识文件的更新版
Med Clin (Barc). 2021 May 7;156(9):463.e1-463.e30. doi: 10.1016/j.medcli.2020.09.022. Epub 2021 Jan 16.
4
FOTROCAN Delphi consensus statement regarding the prevention and treatment of cancer-associated thrombosis in areas of uncertainty and low quality of evidence.关于证据质量低和存在不确定性领域癌症相关血栓形成预防与治疗的FOTROCAN德尔菲共识声明
Clin Transl Oncol. 2017 Aug;19(8):997-1009. doi: 10.1007/s12094-017-1632-3. Epub 2017 Feb 27.
5
National Consensus on the Diagnosis, Risk Stratification and Treatment of Patients with Pulmonary Embolism. Spanish Society of Pneumology and Thoracic Surgery (SEPAR). Society Española Internal Medicine (SEMI). Spanish Society of Thrombosis and Haemostasis (SETH). Spanish Society of Cardiology (ESC). Spanish Society of Medicine Accident and Emergency (SEMES). Spanish Society of Angiology and Surgery Vascular (SEACV).《肺栓塞患者诊断、风险分层与治疗的全国共识》。西班牙肺病与胸外科协会(SEPAR)、西班牙内科协会(SEMI)、西班牙血栓与止血协会(SETH)、西班牙心脏病学会(ESC)、西班牙急诊医学协会(SEMES)、西班牙血管病学与血管外科学会(SEACV)
Arch Bronconeumol. 2013 Dec;49(12):534-47. doi: 10.1016/j.arbres.2013.07.008. Epub 2013 Sep 14.
6
Treatment of venous thromboembolism in patients with cancer: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).癌症患者静脉血栓栓塞症的治疗:意大利止血与血栓形成学会(SISET)指南。
Thromb Res. 2009 Nov;124(5):e32-40. doi: 10.1016/j.thromres.2009.08.006. Epub 2009 Sep 9.
7
Clinical challenges in patients with cancer-associated thrombosis: Canadian expert consensus recommendations.癌症相关血栓形成患者的临床挑战:加拿大专家共识建议。
Curr Oncol. 2015 Feb;22(1):49-59. doi: 10.3747/co.22.2392.
8
Delphi-RAND consensus of the Spanish Society of Internal Medicine on the controversies in anticoagulant therapy and prophylaxis in medical diseases. INTROMBIN Project (Uncertainty in thromboprophylaxis in internal medicine).西班牙内科医学会关于内科疾病抗凝治疗与预防争议的德尔菲-兰德共识。INTROMBIN项目(内科血栓预防的不确定性)
Rev Clin Esp (Barc). 2018 Oct;218(7):358-371. doi: 10.1016/j.rce.2018.04.006. Epub 2018 May 22.
9
Prevention of venous thromboembolism in patients with cancer: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)(1).癌症患者静脉血栓栓塞症的预防:意大利止血与血栓学会(SISET)指南(1)。
Thromb Res. 2012 May;129(5):e171-6. doi: 10.1016/j.thromres.2011.09.002. Epub 2011 Oct 2.
10
[Polish guidelines for the prevention and treatment of venous thromboembolism: 2009 update].[波兰静脉血栓栓塞症预防与治疗指南:2009年更新版]
Pol Arch Med Wewn. 2009;119 Suppl 1:1-69.

引用本文的文献

1
Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?生长分化因子-15在B细胞淋巴增殖性肿瘤中起作用吗?
Indian J Hematol Blood Transfus. 2024 Apr;40(2):213-219. doi: 10.1007/s12288-023-01695-6. Epub 2023 Sep 17.
2
Outcome of antithrombotic therapy in cancer patients with catheter-related thrombosis: a systematic review.癌症患者导管相关血栓形成的抗栓治疗结果:一项系统评价
Front Cardiovasc Med. 2023 Dec 12;10:1290822. doi: 10.3389/fcvm.2023.1290822. eCollection 2023.
3
Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.验证 CoVID-TE 模型作为一种预测 SARS-CoV-2 感染肿瘤患者血栓形成、出血和死亡的工具:由 SEOM 癌症和血栓形成小组进行的研究。
Clin Transl Oncol. 2024 Jan;26(1):171-177. doi: 10.1007/s12094-023-03233-2. Epub 2023 Jun 10.
4
Cost of Venous Thromboembolic Disease in Patients with Lung Cancer: Costecat Study.肺癌患者静脉血栓栓塞症的成本:Costecat 研究。
Int J Environ Res Public Health. 2021 Jan 6;18(2):394. doi: 10.3390/ijerph18020394.
5
New Oral Anticoagulants for Thromboprophylaxis in Patients with Cancer Receiving Chemotherapy: An Economic Evaluation in a Chinese Setting.新型口服抗凝剂在接受化疗的癌症患者中的血栓预防作用:中国情境下的经济学评价。
Clin Drug Investig. 2020 Jul;40(7):653-663. doi: 10.1007/s40261-020-00926-2.
6
ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.ONKOTEV 评分作为预测胰腺癌血栓栓塞事件的工具:一项回顾性分析。
Oncologist. 2020 Feb;25(2):e284-e290. doi: 10.1634/theoncologist.2019-0510. Epub 2019 Oct 22.
7
Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies.实体恶性肿瘤和血液系统恶性肿瘤住院患者静脉血栓栓塞预防及预后的差异
TH Open. 2019 May 30;3(2):e153-e156. doi: 10.1055/s-0039-1692203. eCollection 2019 Apr.

本文引用的文献

1
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.一种癌症相关静脉血栓栓塞的临床预测模型:在两个独立前瞻性队列中的开发与验证研究
Lancet Haematol. 2018 Jul;5(7):e289-e298. doi: 10.1016/S2352-3026(18)30063-2. Epub 2018 Jun 7.
2
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D).癌症合并静脉血栓栓塞症患者中口服 Xa 因子抑制剂与低分子肝素的比较:一项随机试验(SELECT-D)的结果。
J Clin Oncol. 2018 Jul 10;36(20):2017-2023. doi: 10.1200/JCO.2018.78.8034. Epub 2018 May 10.
3
Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH.血小板减少症患者癌症相关血栓形成的管理:国际血栓与止血学会(ISTH)科学和标准化委员会的指南
J Thromb Haemost. 2018 Jun;16(6):1246-1249. doi: 10.1111/jth.14015. Epub 2018 May 8.
4
Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer.多变量临床遗传风险模型预测癌症患者静脉血栓栓塞事件。
Br J Cancer. 2018 Apr;118(8):1056-1061. doi: 10.1038/s41416-018-0027-8. Epub 2018 Mar 28.
5
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.有症状与无症状的内脏静脉血栓形成患者的抗凝治疗结果。
Thromb Res. 2018 Apr;164:69-74. doi: 10.1016/j.thromres.2018.02.143. Epub 2018 Mar 2.
6
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.依度沙班治疗癌症相关静脉血栓栓塞症。
N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12.
7
Outcomes after inferior vena cava filter placement in cancer patients diagnosed with pulmonary embolism: risk for recurrent venous thromboembolism.癌症合并肺栓塞患者行下腔静脉滤器置入术后的结局:复发性静脉血栓栓塞风险。
J Thromb Thrombolysis. 2017 Nov;44(4):489-493. doi: 10.1007/s11239-017-1557-2.
8
Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis.骨髓增殖性肿瘤相关出血和血栓形成的危险因素及管理
Curr Hematol Malig Rep. 2017 Oct;12(5):389-396. doi: 10.1007/s11899-017-0400-3.
9
Thrombophilia Testing and Venous Thrombosis.血栓形成倾向检测与静脉血栓形成
N Engl J Med. 2017 Sep 21;377(12):1177-1187. doi: 10.1056/NEJMra1700365.
10
Patients treated for acute VTE during periods of treatment-related thrombocytopenia have high rates of recurrent thrombosis and transfusion-related adverse outcomes.在与治疗相关的血小板减少症期间接受急性 VTE 治疗的患者,其血栓复发和与输血相关的不良结局发生率较高。
J Thromb Thrombolysis. 2017 Nov;44(4):442-447. doi: 10.1007/s11239-017-1539-4.